Patents Assigned to BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
  • Publication number: 20240165015
    Abstract: Disclosed are a Lactobacillus rhamnosus strain having accession number CCTCC NO: M 2021185, a ferment lysate prepared thereby for regulating skin microecology, and a preparation method for the ferment lysate. The ferment lysate comprises the following components in mass percentages of same in the ferment lysate: 0.2-1% of proteins, 0.3-0.8% of polysaccharides, and 0.2-1% of amino acids. The ferment lysate obtained by using the above bacterial strain for fermentation can strongly inhibit the reproduction and growth of pathogenic bacteria, has a promotion effect on some of probiotics, has a strong inhibition effect on pathogenic hyphae of Candida albicans, can not only generate antimicrobial peptides during fermentation, but also increase the expression level of antimicrobial peptides in skin cells at the genetic level and the protein level, thereby improving skin immunity.
    Type: Application
    Filed: March 24, 2022
    Publication date: May 23, 2024
    Applicant: BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
    Inventors: Zhen LU, Yujie WEI, Yuanjun SUN, Ranran DU, Yan ZHAO, Xueping GUO
  • Publication number: 20240150742
    Abstract: Provided is a gene for efficiently expressing hyaluronic acid hydrolase. A nucleotide sequence of the gene is represented by SEQ ID NO: 4. By truncating a segment of a signal peptide sequence at the N-terminus of a full-length hyaluronic acid hydrolase gene, the Pichia pastoris engineering strain of high level expression genetic engineering hyaluronic acid hydrolase is constructed. The enzyme activity of the hyaluronic acid hydrolase in a fermentation broth obtained by high-density fermentation using the constructed Pichia pastoris engineering strain is up to 4.7×105 U/mL.
    Type: Application
    Filed: March 23, 2021
    Publication date: May 9, 2024
    Applicant: BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
    Inventors: Hao WANG, Tianmeng ZHANG, Rongrong XU, Youheng ZHANG, Xueping GUO, Jingkun HAO
  • Patent number: 11932881
    Abstract: A heparin skeleton synthase originates from Neisseria animaloris, with an amino acid sequence as shown in SEQ ID NO.2 and a nucleotide sequence of the coding gene as shown in SEQ ID NO.1. Its recombinant expression level is 6.8 times that of the existing heparin skeleton synthase KfiA from Escherichia coli K5, and total enzyme activity per fermentation liquor is 5.22 times that of the heparin skeleton synthase KfiA. The heparin skeleton synthase mutants obtained through site-directed mutagenesis of the sites No. 16, No. 25, No. 30, No. 111, No. 165, and No. 172 in the amino acid sequence of the said heparin skeleton synthase all have high expression levels.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: March 19, 2024
    Assignees: SHAN DONG UNIVERSITY, Bloomage Biotechnology Corporation Limited
    Inventors: Juzheng Sheng, Xueping Guo, Jianqun Deng, Fengshan Wang, Zhen Lu, Ranran Du, Liu Sun, Yuanjun Sun
  • Publication number: 20240009107
    Abstract: Disclosed are a hyaluronic acid composition having permeation-promoting effects, a preparation method thereof and the use thereof. Provided is a hyaluronic acid composition, comprising: hyaluronic acid or a salt thereof, an acetylated hyaluronic acid or a salt thereof, and a hydrolyzed hyaluronic acid or a salt thereof. The hyaluronic acid composition of the present application has a small addition amount, can effectively facilitate the absorption of other active ingredients in a formula to achieve synergistic effects, has a small particle size, is uniform, has a fast dissolution rate, has an excellent absorption speed in a product, and is superior to hyaluronic acid treated by means of simple mixing in improving skin hydration. Compared with traditional penetration promoters, the hyaluronic acid composition of the present application causes no damage to the skin and is safe.
    Type: Application
    Filed: November 5, 2021
    Publication date: January 11, 2024
    Applicants: BLOOMAGE BIOTECH (TIANJIN) CO., LTD., BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
    Inventors: Yuling WANG, Xueping GUO, Huixia LV, Liping QIAO, Shujing REN, Ximing WEN, Xia LI, Jing WANG, Feng GENG
  • Publication number: 20230407238
    Abstract: The present application provides a use of a hyaluronic acid or a salt thereof and/or trehalose in stabilizing ergothioneine, an additive for stabilizing ergothioneine, the additive containing the hyaluronic acid or the salt thereof and/or trehalose, and a composition, the composition containing ergothioneine, the hyaluronic acid or the salt thereof, and trehalose. Compared with other auxiliary materials, the hyaluronic acid or the salt thereof and trehalose provided by the present invention can obviously mitigate the damage of a high temperature to ergothioneine, thereby increasing the yield of an ergothioneine powder product. The composition obtained by the present invention has good antioxidant and anti-apoptotic effects.
    Type: Application
    Filed: November 9, 2021
    Publication date: December 21, 2023
    Applicants: BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED, BLOOMAGE BIOTECH (TIANJIN) CO., LTD.
    Inventors: Yujie WEI, Zhen LU, Qingping CHEN, Jie LI, Yuanjun SUN, Wenjuan XIE, Ranran DU, Wenyi GUO, Xueping GUO